BooksSitemapMedicalPharmacologyF
Fabricación de estupefacientes, de sustancias sicotrópicas y de sus precursores by United Nations - 2006 - 376 pages
Factors affecting the production of penicillin in pilot-plant fermentations by William Everett Brown - 1949 - 178 pages
Factors influencing clinical research success by Marion J. Finkel, Tulane University. School of Medicine - 1976 - 174 pages
Facts concerning opium and other dangerous drugs in Manchoukuo by Manchoukuo. Wai wu ju. Diao cha chu - 1937 - 64 pages
Failures after radiotherapy of lip cancer analysed by clinical models by Kim Palmö, Matti Salmo - 1988 - 26 pages
Failures after radiotherapy of lip cancer analysed by clinical models by Kim Palmö, Matti Salmo - 1988 - 26 pages
Family guide to prescription drugs by Smith, Dorothy L - 1985 - 228 pages
Family medical & prescription drug guide by Ira J. Chasnoff - 1995 - 864 pages
Farhang-i dārūʾī by Muḥammad Riz̤ā Tavakkulī Ṣābirī - 1981
Farmaci E Parametri Chimico-Clinici by Achille Patrizio Caputi - 2011 - 241 pages
Farmacia by Michael E. Aulton - 2004 - 681 pages
FARMACIA HOSPITALAR E SUAS INTERFACES COM A SAUDE by JULIO FERNANDES MAIA NETO, Júlio Maia - 316 pages
Farmacocinetica. Utilitā Nella Pratica Clinica Quotidiana by Federico Pea - 2011 - 120 pages
Farmacognosia by F Capasso - 2011 - 489 pages
Farmacognosia Applicata by Raffaele Capasso, Francesco Capasso, Francesca Borrelli, Rocco Longo - 2007 - 174 pages
Farmacognosia Especial by Luis Bravo - 2003 - 356 pages
Farmacognosia generale e applicata by Alessandro Bruni - 1999 - 419 pages
Farmacognòsia: de la natura al medicament by Salvador Máñez Aliño, Rosa Maria Giner Pons - 2005 - 292 pages
Farmacologia by Humphrey P. Rang, Maureen Dale, James M. Ritter, Rod Flower, Graeme Henderson - 2012 - 800 pages
Farmacologia by Humphrey P. Rang, M. Maureen Dale, James M. Ritter - 2008 - 848 pages
Farmacologia Aplicada à Avicultura by João Palermo Neto - 2005 - 366 pages
Farmacologia clinica ematologica by Luciano Vettore, Lucia Zeni, Luciano Vettore - 1986 - 128 pages
Farmacologia Di Genere. E-book. Formato EPub by Flavia Franconi - 2010 - 163 pages
Farmacologia e materia medica omeopatica by Denis Demarque, Jacques Jovanny, Bernard Poitevin - 1999 - 480 pages
Farmacologia e materia medica omeopatica by Denis Demarque, Jacques Jovanny, Bernard Poitevin - 1999 - 480 pages
Farmacologia medica / Medical Pharmacology by Nicandro Mendoza Patiño - 2008 - 934 pages
Farmacologia medica ed elementi di terapia by D.G. Waller, A.G. Renwick, K. Hillier - 2011 - 646 pages
Farmacología by M. M. Dale, H. P. Rang - 2012 - 868 pages
Farmacología by Michelle A. Clark, Richard Finkel, Jose A. Rey, Karen Whalen - 2011 - 608 pages
Farmacología integrada by Clive P. Page, Michael J. Curtis, Morley C. Sutter - 1998 - 606 pages
Farmacología ocular by Josep Eladi Baños Díez, Marian March Pujol - 2002 - 220 pages
Farmacología ocular by Josep Eladi Baños Díez, Marian March Pujol - 2002 - 220 pages
Farmacología Texto y Atlas by Heinz Lüllmann, Lutz Hein, Klaus Mohr - 2010 - 394 pages
Farmacopea mexicana formada y publicada por la Academia farmacéutica de la capital de la República by Academia farmaceutica, Mexico - 1846 - 436 pages
Farmacopea oficial española by Real Academia Nacional de Medicina (Spain) - 1930 - 1037 pages
Fasttrack by Michael D. Randall, Dave A. Kendall, Stephen P. H. Alexander - 2012 - 276 pages
FDA annual report by United States. Food and Drug Administration
FDA compilation of case studies of drug recalls, March 1973 by United States. Food and Drug Administration - 1973 - 72 pages
FDA consumer information by United States. Food and Drug Administration - 1980 - 14 pages
FDA drug approval--a lengthy process that delays the availability of important new drugs by United States. General Accounting Office, United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology - 1980 - 83 pages
FDA drug bulletin by United States. Food and Drug Administration - 1990
FDA drug bulletin by United States. Food and Drug Administration - 1990
FDA drug bulletin by United States. Food and Drug Administration - 1989
FDA drug bulletin by United States. Food and Drug Administration - 1988
FDA drug bulletin by United States. Food and Drug Administration - 1988
FDA drug bulletin by United States. Food and Drug Administration - 1988
FDA drug bulletin by United States. Food and Drug Administration - 1987
FDA drug bulletin by United States. Food and Drug Administration - 1985
FDA drug bulletin by United States. Food and Drug Administration - 1985
FDA drug bulletin by United States. Food and Drug Administration - 1985
FDA drug bulletin by United States. Food and Drug Administration
FDA drug bulletin April 1970 through October 1990 ; FDA medical bulletin March 1991 through June 1993 by United States. Food and Drug Administration. Office of Public Affairs, United States. Public Health Service - 1993 - 101 pages
FDA drug review by United States. General Accounting Office - 1990 - 131 pages
FDA enforcement report by United States. Food and Drug Administration, United States. Food and Drug Administration. Press Office - 1995
FDA enforcement report by United States. Food and Drug Administration - 1994
FDA enforcement report by United States. Food and Drug Administration - 1993
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration - 1992
FDA enforcement report by United States. Food and Drug Administration, United States. Food and Drug Administration. Press Office - 1991
FDA enforcement report by United States. Food and Drug Administration, United States. Food and Drug Administration. Press Office - 1990
FDA enforcement report by United States. Food and Drug Administration, United States. Food and Drug Administration. Press Office
FDA issues by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment - 1985 - 784 pages
FDA issues by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment - 1985 - 784 pages
FDA management and enforcement by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1992 - 388 pages
FDA management and enforcement by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1992 - 388 pages
FDA papers by United States. Food and Drug Administration - 1972
FDA proposals to ease restrictions on the use and sale of experimental drugs by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee - 1987 - 327 pages
FDA regulations by United States. General Accounting Office, United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment - 1992 - 25 pages
FDA regulations by United States. General Accounting Office, United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment - 1992 - 25 pages
FDA review times by Mary R. Hamilton, United States. General Accounting Office, United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment - 1996 - 13 pages
FDA services guide by United States. Food and Drug Administration - 1974 - 29 pages
FDA user fees by United States. General Accounting Office, United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee - 1994 - 43 pages
FDA user fees by United States. General Accounting Office - 1994 - 43 pages
FDA's "exclusivity policy" concerning the labeling claims or "indications for use" of drug products for over-the-counter (OTC) use by United States. Food and Drug Administration - 1985 - 6 pages
FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow by United States. General Accounting Office - 1982 - 43 pages
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1991
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1991
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1991
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1990
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1990
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1990
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1989
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1989
FDA's generic drug approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1989
FDA's generic drug enforcement and approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1992 - 587 pages
FDA's generic drug enforcement and approval process by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1992 - 587 pages
FDA's prescription to over-the-counter drug switch by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1983 - 95 pages
FDA's regulation of the drug "Triazure" by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee - 1976 - 212 pages
FDA's regulation of the marketing of unapproved new drugs by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee - 1984 - 501 pages
FDA's regulation of the marketing of unapproved new drugs by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee - 1984 - 501 pages
FDA's regulation of the marketing of unapproved new drugs by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee - 1984 - 501 pages
FDA's regulation of the new drug Suprol by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee - 1988 - 448 pages
FDA's regulation of the new drug Suprol by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee - 1988 - 448 pages
FDA's regulation of Zomax by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee - 1983 - 555 pages
FDA's regulation of Zomax by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee - 1983 - 555 pages
FDA's reviews of new drugs by United States. General Accounting Office - 1988 - 33 pages
FDA's reviews of new drugs by United States. General Accounting Office - 1988 - 33 pages
FDA/ORA international inspection manual and travel guide by United States. Food and Drug Administration, United States. Food and Drug Administration. Office of Regional Operations, United States. Food and Drug Administration. Division of Emergency and Investigational Operations - 1997 - 197 pages
Federal and state laws (compiled) relating to the manufacture and sale of foods, drugs, insecticides, etc by Standard Remedies Publishing Co, United States, Canada - 1924 - 883 pages
Federal and state laws (compiled) relating to the manufacture and sale of foods, drugs, insecticides, etc by Standard Remedies Publishing Co, United States, Canada - 1924 - 883 pages
Federal control of new drug testing is not adequately protecting human test subjects and the public, Food and Drug Administration, Department of Health, Education, and Welfare by United States. General Accounting Office - 1976 - 85 pages
Federal control of new drug testing is not adequately protecting human test subjects and the public, Food and Drug Administration, Department of Health, Education, and Welfare by United States. General Accounting Office - 1976 - 85 pages
Federal drug abuse and drug dependence prevention, treatment, and rehabilitation act of 1970 by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Alcoholism and Narcotics - 1970
Federal drug abuse and drug dependence prevention, treatment, and rehabilitation act of 1970 by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Alcoholism and Narcotics - 1970
Federal drug enforcement by United States. Congress. Senate. Committee on Government Operations. Permanent Subcommittee on Investigations - 1975
Federal drug enforcement by United States. Congress. Senate. Committee on Government Operations. Permanent Subcommittee on Investigations - 1975
Federal drug enforcement by United States. Congress. Senate. Committee on Government Operations. Permanent Subcommittee on Investigations - 1975
Federal drug enforcement by United States. Congress. Senate. Committee on Government Operations. Permanent Subcommittee on Investigations - 1975
Federal food, drug and cosmetic act by United States. Congress. House. Committee on Interstate and Foreign Commerce - 1951 - 229 pages
Federal regulation of the drug industry by Vincent A. Kleinfeld, Practising Law Institute - 1974 - 344 pages
Fibrinolytics and antifibrinolytics - 1978 - 653 pages
Fighting disease with drugs by National Conference of Pharmaceutical Research - 1931 - 230 pages
Fighting meth in America's heartland by United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources - 2006 - 159 pages
Fighting meth in America's heartland by United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources - 2006 - 159 pages
Filing Patents Online by Sarfaraz K. Niazi - 2003 - 464 pages
Filosofia farmaceútica o la farmacia reducida a sus verdaderos principios by Gregorio Bañares, Imprenta Real (Madrid) - 1814
Filosofia farmaceútica o la farmacia reducida a sus verdaderos principios by Gregorio Bañares, Imprenta Real (Madrid) - 1814
Filosofia farmaceútica o la farmacia reducida a sus verdaderos principios by Gregorio Bañares, Imprenta Real (Madrid) - 1814
Filosofía farmacéutica ó La farmacia reducida a sus verdaderos principios by Gregorio Bañares, Imprenta Real (Madrid) - 1804 - 304 pages
Filthy food, dubious drugs, and defective devices by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1991 - 24 pages
Final report by Great Britain. Committee on Cost of Prescribing - 1959 - 108 pages
Final report by Great Britain. Committee on Cost of Prescribing - 1959 - 108 pages
Final report of the Special Senate Committee to Investigate the Drug Laws of Pennsylvania by Pennsylvania. General Assembly. Senate. Special Committee to Investigate the Drug Laws of Pennsylvania - 1978
Final report to the Commissioner of Food and Drugs by United States. Food and Drug Administration - 1969 - 243 pages
Financial Analysis in Pharmacy Practice by Keith N. Herist, Brent L. Rollins, Ph.D., Matthew Perri, III Ph.D. - 2011 - 225 pages
First Congress of the Hungarian Pharmacological Society by József Knoll - 1973
First International Symposium on Cell Biology and Cytopharmacology, Venice, Italy - 1971 - 475 pages
Fixed drug combinations by Medical Advisory Council (Merck, Sharp & Dohme International) - 1980 - 73 pages
Flavonoids and Other Polyphenols - 2001 - 448 pages
Flesh of the gods by Peter T. Furst - 1990 - 304 pages
Flesh of the gods by Peter T. Furst - 1972 - 304 pages
Flora of the British Isles by Arthur Roy Clapham, Thomas Gaskell Tutin, E. F. Warburg - 1962 - 1269 pages
Flow Cytometry in Drug Discovery and Development - 2011 - 368 pages
Flow Cytometry in Drug Discovery and Development - 2010 - 352 pages
Focus on pharmacy, 1962 by American Pharmaceutical Association. Michigan Branch - 1962 - 97 pages
Focus on pulmonary pharmacology and toxicology by Mannfred A. Hollinger - 1989 - 152 pages
Follow-on biologics by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions - 2008 - 78 pages
Folyl and antifolyl polyglutamates by I. David Goldman, Joseph R. Bertino, Bruce Chabner - 1983 - 425 pages
Food & drug regulation by Stephen Wilson, American Council on Public Affairs - 1942 - 177 pages
Food & drug regulation by Stephen Wilson, American Council on Public Affairs - 1942 - 177 pages
Food and Drug Administration's Critical Path Initiative by United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 2008 - 42 pages
Food and Drug Administration's Critical Path Initiative by United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 2008 - 42 pages
Food and Drug Administration, resources for Division of Scientific Investigations have been reduced by United States. General Accounting Office - 1986 - 8 pages
Food and drug circular no. 1- by United States. Food and Drug Administration - 1944
Food and drug compliance by George M. Burditt, Russell D. Munves, Practising Law Institute - 1984 - 320 pages
Food and drug review by United States. Food and Drug Administration - 1931
Food and drug review by United States. Food and Drug Administration - 1928
Food and drug review by Chemistry Bureau - 1927
Food and drug review by United States. Food and Drug Administration - 1927
Food and drug review by Chemistry Bureau - 1926
Food and drug review by Chemistry Bureau - 1925
Food and drug review by Chemistry Bureau - 1924
Food and drug review by Chemistry Bureau - 1923
1 2